INS and diabetes mellitus: Transient activation of O-GlcNAc signaling is cytoprotective but its sustained elevation that is found in diabetes is involved in impaired mitochondrial function, abnormal insulin metabolic signaling, endothelial dysfunction, myocardial excitation–contraction coupling, and cardiomyocyte apoptosis [5,87,88,89,90,91].